New research finds obstructive sleep apnea is associated with higher muscle mass index but lower muscle density, signaling ...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

Findings published in The American Journal of Pathology identify GLUD1 enzyme as a potential therapeutic target for muscle restoration through metabolic reprogramming, addressing clinically unmet need ...

A person may inherit the genetic changes responsible for muscular dystrophy. These genetic changes can also occur due to spontaneous genetic mutations. In either case, the disease is not preventable.

Duchenne muscular dystrophy (DMD) is caused by a mutation in the DMD gene that prevents dystrophin production, leading to progressive muscle weakness and early mobility challenges. The 2018 DMD ...

A growing body of research points to this overlooked structure as the missing piece in back pain treatment Back pain remains one of the most common health complaints worldwide, affecting an estimated ...

Fat, not skeletal muscle, accounted for most of the weight loss. According to the study, GLP-1 medicines reduced body fat in obese mice much more than lean body mass, and fat and liver mass fell ...